Evidence map›Paper›PMID 41251148›Full record

ArticleEpilepsia2026

Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study.

Joseph Sullivan, M Scott Perry, Ingrid E Scheffer, James Wheless, Susana Boronat, Andreas Brunklaus, Linda Laux, Anup D Patel, Colin Roberts, Dennis Dlugos and 19 more

Registry-linked trialAbstract read
In one paragraph

Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04537832 (ENVISION), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04537832 terminatednot on this map

ENVISION: Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

TypeobservationalSponsorEncoded TherapeuticsRan2021 to 2023Enrolled58ConditionsDravet SyndromeArmsNo Intervention
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Joseph SullivanUniversity of California at San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-2081-8988
M Scott PerryCook Children's Medical Center, Fort Worth, Texas, USA.ORCID https://orcid.org/0000-0002-1825-846X
Ingrid E SchefferEpilepsy Research Centre, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.ORCID https://orcid.org/0000-0002-2311-2174
James WhelessLe Bonheur Children's Hospital, Memphis, Tennessee, USA.ORCID https://orcid.org/0000-0002-4735-3431
Susana BoronatHospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0001-7096-5578
Andreas BrunklausUniversity of Glasgow, Glasgow, Scotland, UK.ORCID https://orcid.org/0000-0002-7728-6903
Linda LauxAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Anup D PatelNationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0001-9313-1541
Colin RobertsDoernbecher Children's Hospital, Portland, Oregon, USA.
Dennis DlugosChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-3088-7645
Deborah HolderChildren's Hospital Los Angeles, Los Angeles, California, USA.ORCID https://orcid.org/0000-0001-5532-4764
Kelly KnuppChildren's Hospital Colorado, Aurora, Colorado, USA.ORCID https://orcid.org/0000-0002-1967-0827
Matt LallasNicklaus Children's Hospital, Miami, Florida, USA.
Steven PhillipsMulticare Health System, Tacoma, Washington, USA.ORCID https://orcid.org/0009-0007-4704-2258
Eric SegalNortheast Regional Epilepsy Group, Hackensack, New Jersey, USA.ORCID https://orcid.org/0000-0002-9986-6394
Dennis LalCleveland Clinic Lerner Research Institute, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-5173-9636
Elaine WirrellMayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-3015-8282
Sameer ZuberiRoyal Hospital for Children, Glasgow, Scotland, UK.ORCID https://orcid.org/0000-0002-4489-4697
Gerard GioiaChildren's National Hospital, Washington, DC, USA.ORCID https://orcid.org/0000-0001-7112-5968
Rebecca ShafferCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID https://orcid.org/0000-0001-6935-4403
Madison M BerlChildren's National Hospital, Washington, DC, USA.ORCID https://orcid.org/0000-0002-2469-1518
Mary WojnaroskiNationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0009-0006-5595-0419
Sarah ChristensenEncoded Therapeutics, South San Francisco, California, USA.
Alexander KingEncoded Therapeutics, South San Francisco, California, USA.ORCID https://orcid.org/0009-0000-7380-7647
Emma S JamesEncoded Therapeutics, South San Francisco, California, USA.ORCID https://orcid.org/0000-0003-2672-9652
Maria Candida VilaEncoded Therapeutics, South San Francisco, California, USA.ORCID https://orcid.org/0000-0003-4593-5822
Norman HuangEncoded Therapeutics, South San Francisco, California, USA.
Jacqueline S GofshteynEncoded Therapeutics, South San Francisco, California, USA.ORCID https://orcid.org/0000-0003-3354-6176
Salvador RicoEncoded Therapeutics, South San Francisco, California, USA.ORCID https://orcid.org/0000-0002-1508-8717

Funding

Encoded Therapeutics
6 · The paper itself

Abstract

objectiveDravet syndrome (DS) is a developmental and epileptic encephalopathy characterized by drug-resistant seizures and developmental slowing. Although cognitive and executive function deficits have been described, their early trajectory is not well understood.

methodsThe prospective ENVISION natural history study (NCT04537832) assessed cognitive, executive, and adaptive function in children younger than 5 years of age with SCN1A+ DS every 6 months for up to 2 years using Bayley Scales of Infant and Toddler Development, 3rd Edition (BSID-III), Wechsler Preschool & Primary Scale of Intelligence, 4th Edition (WPPSI-IV), Vineland Adaptive Behavior Scales, 3rd Edition (VABS-3), Behavior Rating Inventory of Executive Function - Preschool Version (BRIEF-P), and Pediatric Evaluation of Disability Inventory (PEDI).

resultsFifty-eight children were enrolled, with 47% younger than age 2 years. At least 80% of children did not achieve age-appropriate milestones. Mean BSID-III Cognitive raw scores increased minimally, with age-equivalent gains of only 3 months over 1.5 years. Mean Cognitive Composite scores declined significantly by Month 12 (from 81.6 to 72.2; change: -11.0, 95% confidence interval [CI]: -15.3 to -6.8), signaling a widening gap compared with neurotypical development. Executive function worsened, with mean BRIEF-P Global Executive Composite T-scores increasing by 3.2 points/year. For some participants, scores were 5 standard deviations (SD) above the normative mean, reflecting abilities profoundly below age expectations (bottom .00003% of the population). Adaptive functioning worsened, with mean VABS-3 Adaptive Behavior Composite decreasing from 78.7 to 68.1 over 1.5 years (change: -9.0, 95% CI: -11.9 to -6.1) and greater decline among children <2 years at enrollment, with scores decreasing by ~15 points (1 SD). Over half of children >3 years could not remove clothing independently; and when placed on a toilet, 48% could not use it. SIGNIFICANCE: Infants and young children with SCN1A+ DS show significant and progressive developmental slowing across several domains, highlighting urgent need for therapies to mitigate the devastating impact on individuals and families.

Indexed as

Epilepsies, MyoclonicExecutive FunctionNAV1.1 Voltage-Gated Sodium ChannelChild, PreschoolDisease ProgressionFemaleHumansInfantMaleNeuropsychological TestsProspective StudiesNAV1.1 Voltage-Gated Sodium ChannelSCN1A protein, humanadaptive functioningdevelopmental and epileptic encephalopathydevelopmental delaynatural historyseizures

Identifiers

PMID41251148
PMCPMC13007829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.